Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (101-110 of 211) with videos related to

Pageof 22
Sort By:
The European Respiratory Journal|January 13, 2019
Telomere length and genetic variant associations with interstitial lung disease progression and survivalChad A Newton, Justin M Oldham, Brett Ley, et al.
Ebiomedicine|June 22, 2021
50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort studyBrenda M Juan Guardela, Jiehuan Sun, Tong Zhang, et al.
BMJ Open Respiratory Research|July 7, 2020
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO RegistryLaurie D Snyder, Christopher Mosher, Colin H Holtze, et al.
Annals of the American Thoracic Society|April 16, 2021
Associations of D-Dimer with Computed Tomographic Lung Abnormalities, Serum Biomarkers of Lung Injury, and Forced Vital Capacity: MESA Lung StudyJohn S Kim, Michaela R Anderson, Elana J Bernstein, et al.
BMC Pulmonary Medicine|July 16, 2020
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyFranck F Rahaghi, Zeenat Safdar, Anne Whitney Brown, et al.
BMJ Open Respiratory Research|February 1, 2023
Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosisYong Huang, Rob Guzy, Shwu-Fan Ma, et al.
Pediatric Pulmonology|December 2, 2004
Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung diseaseRichard B Moss, Nicole Mayer-Hamblett, Jeffrey Wagener, et al.
Scientific Reports|July 1, 2017
Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesDavid N O'Dwyer, Katy C Norman, Meng Xia, et al.
JCI Insight|February 18, 2025
CD103+ dendritic cell-fibroblast crosstalk via TLR9, TDO2, and AHR signaling drives lung fibrogenesisHannah Carter, Rita Medina Costa, Taylor S Adams, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory SarcoidosisNadera J Sweiss, Imre Noth, Mehdi Mirsaeidi, et al.
Pageof 22

Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|January 13, 2019
Telomere length and genetic variant associations with interstitial lung disease progression and survivalChad A Newton, Justin M Oldham, Brett Ley, et al.
Ebiomedicine|June 22, 2021
50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort studyBrenda M Juan Guardela, Jiehuan Sun, Tong Zhang, et al.
BMJ Open Respiratory Research|July 7, 2020
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO RegistryLaurie D Snyder, Christopher Mosher, Colin H Holtze, et al.
Annals of the American Thoracic Society|April 16, 2021
Associations of D-Dimer with Computed Tomographic Lung Abnormalities, Serum Biomarkers of Lung Injury, and Forced Vital Capacity: MESA Lung StudyJohn S Kim, Michaela R Anderson, Elana J Bernstein, et al.
BMC Pulmonary Medicine|July 16, 2020
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyFranck F Rahaghi, Zeenat Safdar, Anne Whitney Brown, et al.
BMJ Open Respiratory Research|February 1, 2023
Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosisYong Huang, Rob Guzy, Shwu-Fan Ma, et al.
Pediatric Pulmonology|December 2, 2004
Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung diseaseRichard B Moss, Nicole Mayer-Hamblett, Jeffrey Wagener, et al.
Scientific Reports|July 1, 2017
Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesDavid N O'Dwyer, Katy C Norman, Meng Xia, et al.
JCI Insight|February 18, 2025
CD103+ dendritic cell-fibroblast crosstalk via TLR9, TDO2, and AHR signaling drives lung fibrogenesisHannah Carter, Rita Medina Costa, Taylor S Adams, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory SarcoidosisNadera J Sweiss, Imre Noth, Mehdi Mirsaeidi, et al.
Pageof 22